PCN79 Pharmacoeconomic Evaluation of Acute Myeloid Leukemia and MDS Syndromes (Intermediate and High Risk) Treatment With Azacitidine in the Russian Federation
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2119
https://www.valueinhealthjournal.com/article/S1098-3015(12)03833-8/fulltext
Title :
PCN79 Pharmacoeconomic Evaluation of Acute Myeloid Leukemia and MDS Syndromes (Intermediate and High Risk) Treatment With Azacitidine in the Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03833-8&doi=10.1016/j.jval.2012.08.2119
First page :
A423
Section Title :
Cancer
Open access? :
No
Section Order :
772